Pretreatment Prostate-Specific Antigen (PSA) Velocity and Doubling Time Are Associated With Outcome but Neither Improves Prediction of Outcome Beyond Pretreatment PSA Alone in Patients Treated With Radical Prostatectomy
- 1 August 2009
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 27 (22), 3591-3597
- https://doi.org/10.1200/jco.2008.19.9794
Abstract
Purpose Controversy exists as to whether current pretreatment prostate-specific antigen (PSA) dynamics enhance outcome prediction in patients undergoing treatment for prostate cancer. We assessed whether pretreatment PSA velocity (PSAV) or doubling time (PSADT) predicted outcome in men undergoing radical prostatectomy and whether any definition enhanced accuracy of an outcome prediction model. Patients and Methods The cohort included 2,938 patients with two or more PSA values before radical prostatectomy. Biochemical recurrence (BCR) occurred in 384 patients, and metastases occurred in 63 patients. Median follow-up for patients without BCR was 2.1 years. We used univariate Cox proportional hazards regression to evaluate associations between published definitions of PSADT and PSAV with BCR and metastasis. Predictive accuracy was assessed using the concordance index. Results On univariate analysis, two of 12 PSADT and four of 10 PSAV definitions were univariately associated with both BCR and metastasis (P < .05). One PSADT and one PSAV definition had a higher predictive accuracy for BCR over PSA alone, and four PSAV definitions improved prediction of metastasis. However, the improvements in predictive accuracy were small, associated with wide CIs, and markedly reduced if additional predictors of stage and grade were included alongside PSA. Modeling with random variables suggests that similar results would be expected by chance. Conclusion We found no clear evidence that any definition of PSA dynamics substantially enhances the predictive accuracy of a single pretreatment PSA alone.Keywords
This publication has 30 references indexed in Scilit:
- Systematic Review of Pretreatment Prostate-Specific Antigen Velocity and Doubling Time As Predictors for Prostate CancerJournal of Clinical Oncology, 2009
- Is Prostate-Specific Antigen Velocity Useful in Early Detection of Prostate Cancer? A Critical Appraisal of the EvidenceJNCI Journal of the National Cancer Institute, 2007
- Comparison of Methods for Calculating Prostate Specific Antigen VelocityJournal of Urology, 2006
- Detection of Life-Threatening Prostate Cancer With Prostate-Specific Antigen Velocity During a Window of CurabilityJNCI Journal of the National Cancer Institute, 2006
- Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal for a Standardized DefinitionJournal of Clinical Oncology, 2006
- Preoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical ProstatectomyJNCI Journal of the National Cancer Institute, 2006
- Does PSA Velocity Predict Prostate Cancer in Pre-Screened Populations?European Urology, 2006
- Prostate‐specific antigen velocity and survival for patients with hormone‐refractory metastatic prostate carcinomaCancer, 2005
- Preoperative PSA Velocity Is an Independent Prognostic Factor for Relapse After Radical ProstatectomyJournal of Clinical Oncology, 2005
- Use of pretreatment prostate-specific antigen doubling time to predict outcome after radical prostatectomyProstate Cancer and Prostatic Diseases, 2000